Ex-Janitor Becomes A Billionaire Pandemic Recovery Boosts His Korean Travel Superapp Korea Unicorn - Korea Startup HEAD TOPICS
Ex-Janitor Becomes A Billionaire Pandemic Recovery Boosts His Korean Travel Superapp
10/21/2022 2:45:00 PM Ex-Janitor Becomes A Billionaire Pandemic Recovery Boosts His Korean Travel Superapp
Korea Unicorn Korea Startup
Source Forbes
Ex-Janitor Becomes A Billionaire Pandemic Recovery Boosts His Korean Travel Superapp As the world opens back up and industries from travel to hotels rebound from the depths of the Covid-19 pandemic, South Korean travel superapp Yanolja posted strong first-quarter sales growth in its first-ever quarterly report as it prepares to go public. Forbesestimates Lee and his family’s net worth at $2 billion. (Forbesapplies a 10% discount to private company valuations.)Founded in 2005, Yanolja—which means “Hey, let’s play” in Korean—has expanded from short-stay hotels to transportation and, more recently, cloud-computing software that helps hotels and travel companies digitize business processes. The company reported that first-quarter revenue rose 19% year over year to 100.5 billion won ($80 million), while net income decreased slightly to 8.8 billion won from 9 billion won during the same period. Read more:
Forbes » CDC and FDA clear Novavax vaccine as a first COVID booster for adults FDA, CDC sign off on Novavax Covid-19 vaccine as a first booster shot CNN FDA OKs Novavax COVID Vaccine as First Booster Shot At first in-person AFN convention since COVID, Rep. Mary Peltola takes center stage Inside the only lithium producer in the U S which provides the critical mineral used in batteries by Tesla EV makers
Silver Peak has gained newfound attention in recent years as the energy and transportation sectors race to wean themselves off climate-warming fossil fuels. Read more >> CDC and FDA clear Novavax vaccine as a first COVID booster for adultsU.S. regulators on Wednesday granted emergency use authorization for the COVID-19 vaccine made by Novavax to be used as a booster. The shot can now be administered to people 18 and older who received the Novavax, Pfizer, Moderna, or Johnson & Johnson vaccines as their primary series, at least six months after the completion of those initial doses, according to the Food and Drug Administration.The Novavax booster, however, should not be given to those who have already been boosted with one or more booster doses of the other approved vaccines, the agency said in a factsheet for health care providers. Time to open up liability... all drug producers make huge money with no liability FDA, CDC sign off on Novavax Covid-19 vaccine as a first booster shot CNNThe US Food and Drug Administration authorized Novavax’s Covid-19 vaccine for use as a first booster dose among adults 18 and older, at least six months after completing a primary Covid-19 vaccine series. But the self proclaimed experts who have the most to gain from vaccinating a demographic at statistically zero risk using a shot aimed at a variant that no longer exists told us it was a good idea. Trust the experts! POTUS What do we call intervention these days! How and who should be held for the MIS-INFORMATION and millions hurt, and financially effected on how these Thoughts were reported in PAPERS!! GavinNewsom AirTalk LAMayoralRace22 Corruption in high P Idiots FDA OKs Novavax COVID Vaccine as First Booster ShotOn Wednesday, the FDA approved Novavax Inc.'s protein-based vaccine as a first booster dose. Until now, it had only been approved as a two-dose primary series. At first in-person AFN convention since COVID, Rep. Mary Peltola takes center stageMuch of the convention’s focus was on all that’s happened during the pandemic, from floods of funding to new policies and programs for Indigenous communities. 🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥 South Korean Super App Goes Down, Putting a Halt on LifeA days-long outage at Kakao has led to the resignation of a co-CEO and a reckoning over Big Tech’s extensive grip over the South Korean economy. We simply cannot let our daily lives and strategic infrastructure be managed by private companies with no oversight. Their incentives very often are not aligned with ours (an euphemism) South Korean messaging app Kakao's Co-CEO resigns following outageSouth Korea's most popular messaging app, used by about 90% of the country's population, is having a very bad week, and one of its CEOs just resigned stake in July last year for $1.October 20, 2022, 9:34 PM · 5 min read U.Novavax’s Covid-19 vaccine is now available in the United States for use as a first booster dose for people 18 and older.Written by By Cara Murez HealthDay Reporter THURSDAY, Oct. 7 billion, valuing Yanolja at $6.7 billion. regulators on Wednesday granted emergency use authorization for the COVID-19 vaccine made by Novavax to be used as a booster. At that valuation, Forbes estimates Lee and his family’s net worth at $2 billion. Previously, the Novavax vaccine was used only as a two-dose primary series. ( Forbes applies a 10% discount to private company valuations.The Novavax booster, however, should not be given to those who have already been boosted with one or more booster doses of the other approved vaccines, the agency said in a fact sheet for health care providers .) Founded in 2005, Yanolja—which means “Hey, let’s play” in Korean—has expanded from short-stay hotels to transportation and, more recently, cloud-computing software that helps hotels and travel companies digitize business processes.'s protein-based vaccine as a first booster dose. The company reported that first-quarter revenue rose 19% year over year to 100. Monica Gandhi, an infectious disease doctor and professor of medicine at the University of California, San Francisco, about the FDA decision to only allow the Novavax vaccine as a first booster.S.5 billion won ($80 million), while net income decreased slightly to 8.8 billion won from 9 billion won during the same period. . Lee Su-jin, founder of Yanolja, poses for a photograph inside a mock-up motel room at the company's headquarters in Seoul, South Korea. Offering another vaccine choice may help increase COVID-19 booster vaccination rates for these adults. SeongJoon Cho/Bloomberg Yanolja makes most of its money by taking a cut from bookings and charging hotels and travel companies to advertise on its platform.. “According to CDC data, almost 50 percent of adults who received their primary series have yet to receive their first booster dose. In recent years, Yanolja has been expanding its cloud-based business, such as management systems that help hotels manage reservations and big data analytics that predict customer behavior. Revenue from its cloud business contributed 20. So I don’t see any point in that,” Gandhi added. Novavax has been a late comer on the vaccine scene in the US, though it has been widely used in many other countries, including as a booster dose in Europe, Japan, Australia, New Zealand, Switzerland and Israel.5% to Yanolja’s total sales in the first quarter, up from about 8.5% in calendar year 2021. Up until now, as a two-dose primary series. The company said in its first-quarter report that non-face-to-face digital services have been spreading across the leisure industry since the start of the pandemic. So that’s why we’re excited about this in the US,” Dr. The Novavax vaccine uses a more traditional approach to fighting the virus, teaching the immune system to recognize modified fragments of the coronavirus spike protein. It also noted that more hotels are using software to reduce costs and increase efficiency during the pandemic. The Centers for Disease Control and Prevention said the Novavax booster is an option for some people who may be unable to receive an mRNA vaccine such Pfizer’s or Moderna’s because of an allergy to a component of these shots, or because of “a history of a severe allergic reaction (such as anaphylaxis) after a previous dose of an mRNA COVID-19 vaccine, or a lack of availability of an mRNA vaccine. Local reported in April that Yanolja is planning to list on the Nasdaq in the third quarter this year. In addition to SoftBank, Yanolja’s other investors include Singaporean sovereign-wealth fund GIC, online travel giant Booking. Boosters, health experts have said, are essential to keep people protected against severe outcomes of COVID-19. Protein-based vaccines like the Novavax shot teach the immune system to recognize little modified pieces of the virus that the vaccine is targeting.com and SkyLake Investment, a Korean private equity firm led by former Samsung Electronics executive Chin Dae-je. . The Novavax vaccine uses an older and more conventional technology called recombinant protein, which has been used for decades in other vaccines targeting influenza, shingles, human papillomavirus (HPV) and hepatitis B.S.